Silent Lapse: How the Expiry of RoHS Entry 45 Exposes Europe’s Primary Explosive Chemistry Dependency

Nine days ago, the European Union’s legal cover for the use of primary explosive compounds in electric and electronic initiators (EEI) quietly expired. Commission Delegated Directive (EU) 2021/647 — which added Entry 45 to Annex III of the RoHS 2 Directive (2011/65/EU) — granted a five-year exemption from 20 April 2021 for lead diazide, lead styphnate, lead dipicramate, orange lead (lead tetroxide), lead dioxide, and barium chromate in civil-professional EEI. That exemption expired on 20 April 2026. As of this writing, no renewal delegated directive has been published in the Official Journal of the European Union.

The compliance media has not noticed. Trade press coverage of RoHS deadlines in 2026 is focused almost entirely on the July expiries — entries 6(c), 7(c)-I, and 21 — affecting brass connectors, ceramic capacitors, and display glass. Entry 45, which covers the functional explosives chemistry in every civilian detonator manufactured in the European Union, has passed its deadline in silence.

For ISC’s audience, the significance extends well beyond civil EEI compliance. Lead styphnate is the primary initiating explosive in the vast majority of NATO-standard centrefire small-arms primers. The civil regulatory framework and the military supply chain share the same chemistry, the same European manufacturing base, and — increasingly — the same research development pipeline for substitution. What happens to the civil exemption regime is a leading indicator of where the military primer chain will be under pressure next.

What Entry 45 Actually Covered

Annex III Entry 45, as set out in Commission Delegated Directive (EU) 2021/647, permitted six lead and hexavalent chromium compounds in EEI for civil professional use. The technical function of each compound within the initiator chain is distinct and, the primary source evidence shows, not interchangeable with current alternatives.

The Austin Detonator s.r.o. application — the primary source document lodged with Oeko-Institut for Pack 28 — describes the fundamental constraint precisely. Primary explosive compounds must achieve reliable DDT at microsecond timescales in quantities measured in milligrams, while simultaneously being stable enough at manufacturing and storage temperatures to be safely handled. That combination of extreme sensitivity to initiation stimuli with robust thermal and chemical stability over the product’s rated service life has defined the specification for primary explosives since the late nineteenth century. Lead-based compounds satisfy it. Identified candidates for substitution, after more than two decades of systematic R&D, do not.

Twenty Years of Substitution Failure

The Austin Detonator application documents R&D expenditure on Pb and Cr(VI) substitution running from 2012 through 2016, with costs rising 26 per cent over that period as REACH and RoHS II obligations intensified. The company has been the lead REACH registrant for lead azide (CAS: 13423-46-9) — the fundamental REACH registration on which the entire European EEI sector’s legal ability to use the substance depends — while simultaneously funding research into the compounds that would replace it.

Four candidate substitute groups were evaluated against the essential performance matrix: high nitrogen derivatives and their salts; heterocyclic derivatives; complex azide compounds; and amino compounds. None satisfied the combined requirements for initiating strength, thermal stability, synthesis complexity, toxicity profile, and compatibility with existing manufacturing technology. The test results are documented in the Pack 28 file: every column carries either “not OK” or “—” (not assessed due to prior disqualification on another criterion).

The thermal stability requirement deserves particular attention given its relevance to military applications. EEI used in deep mining must function reliably at ambient temperatures of 150–200°C; some product specifications guarantee function to 245°C. This is not an exotic niche. It is an industrial standard that mirrors the thermal endurance requirements placed on military primers exposed to direct sunlight, desert environments, or storage in uncontrolled facilities. Any substitute that fails this criterion in the civil context would fail it in the military context also.

One candidate compound — diazodinitrophenol (DDNP) — was explicitly evaluated and rejected on occupational health grounds. Workers involved in development activities experienced non-specific health effects including headaches, abdominal pain, and nausea. The SFEPA submission to the consultation adds a further structural irony: orange lead, which had been trialled as a substitute for lead chromate, was itself placed on REACH Annex XIV as a Substance of Very High Concern (SVHC) before it could be industrialised at scale — a substitute becoming restricted before it could replace the substance it was intended to replace.

The European Manufacturing Base

The Named Applicants for Entry 45 renewal are not peripheral actors in the European explosives sector. They represent the significant majority of civil EEI production capacity on the continent.

The SFEPA submission places the market scale in context. Tens to hundreds of millions of EEI are placed on the EU market annually. Some member companies derive approximately 40 per cent of their revenue from lead-containing explosives and pyrotechnic products. The French explosives sector alone accounts for approximately €20 billion in annual sales and more than 55,000 employees; SFEPA members operate more than 70 SEVESO upper-tier sites, representing over 10 per cent of all such sites in France.

SFEPA’s conclusion in its submission is unambiguous: a ban on EEI containing lead compounds “would make it impossible to market a significant proportion of the IEEs sold and used each year in the European Union,” causing supply disruptions affecting mining, construction, demolition, and integrated rescue systems.

The Civil–Military Chemistry Bridge

RoHS Directive 2011/65/EU applies to electrical and electronic equipment in the civil domain. Military equipment is excluded from its scope under Article 2(4)(a). Entry 45, therefore, has no direct legal effect on the procurement of military detonators or the manufacture of small-arms primers under the authority of Directive 2009/43/EC (the intra-EU transfer of defence products directive). The regulatory perimeter is clear.

The chemistry, however, does not respect that perimeter.

Lead styphnate — normal lead styphnate, lead(II) 2,4,6-trinitroresorcinate — is the standard oxidising sensitiser in the primer composition of NATO 5.56×45 mm, 7.62×51 mm, 9×19 mm, and the overwhelming majority of other centrefire cartridges produced by Western manufacturers. The European small-arms ammunition production base — RUAG Ammotec, Sellier & Bellot (CZ Group), MEN Metallwerk Elisenhuette (CBC Global), Fiocchi, MESKO (PGZ), Nammo, BAE Systems Radway Green, Nitro-Chem — relies on the same compound that Austin Detonator, Titanobel, and NITROERG use in their civil-professional detonators.

The civil exemption regime matters to defence procurement planners for three distinct reasons. First, the European primary explosive manufacturing and supply chain is shared. Facilities that produce lead styphnate or lead diazide for civil EEI often supply, or share infrastructure with, operations servicing the military primer chain. Regulatory disruption to the civil sector affects lead time and cost visibility across both. Second, the R&D programme for lead-free civil initiators is, in practice, the R&D programme that will eventually produce lead-free military primers. Austin Detonator’s twenty-plus years of failed substitution research is the same body of knowledge that defence prime contractors will need to draw on when REACH Authorisation pressure eventually reaches military cartridge primers — as it will. Third, NITROERG S.A.’s presence in the Pack 28 applicant list as part of PGZ illustrates that the civil/military boundary at the producer level is, in several cases, an accounting line rather than a physical one.

The Regulatory Architecture and What Comes Next

The Oeko-Institut was contracted by DG ENV to conduct the Pack 28 assessment, which covers five exemption renewal requests including Entry 45. A stakeholder consultation ran from 6 June to 1 August 2025. Contributions were received from EPC Groupe and Orica; the Austin Detonator, Titanobel, NITROERG, Lacroix, and SFEPA submissions were lodged with the original application. The assessment report from Oeko-Institut is not yet published. No Commission delegated directive renewing Entry 45 has appeared in EUR-Lex.

The SFEPA request — a five-year extension from the 20 April 2026 expiry, taking the new exemption to approximately 2031 — represents the industry’s assessment of the minimum R&D runway required to produce even conditionally viable substitutes. That timeline is consistent with Austin Detonator’s internal assessment, which declines to specify a projected completion date for a lead-free primary explosive. The SFEPA submission also identifies an additional complicating factor: REACH regulation is lengthening the qualification cycle for any new substitute, since a candidate compound that achieves the necessary energetic performance profile must itself survive REACH evaluation before it can be industrialised — the catch-22 that destroyed the orange lead substitution pathway.

Beyond the immediate Entry 45 question, the ECHA lead restriction dossier — which covers lead compounds broadly and has progressively tightened Authorisation conditions under REACH Annex XIV — represents a parallel and longer-term pressure on the entire Pb-based initiation chemistry stack. The civil exemption under RoHS and the REACH Authorisation pathway are not the same instrument, but they draw on the same evidence base and the same substitution research. If the civil EEI sector cannot demonstrate viable alternatives within the next five-year window, the REACH pressure on lead styphnate in military primer compositions will arrive before a viable replacement is ready.

Three Scenarios

Scenario A — Renewal directive published (most probable). The Commission publishes a new delegated directive granting a further five-year exemption consistent with the SFEPA and Austin Detonator requests. The legal gap is closed retrospectively through the directive’s entry into force date. European EEI production continues without structural interruption. The REACH shadow remains unresolved but deferred. This is the baseline expectation and is consistent with the Commission’s historical treatment of exemptions where substitution has demonstrably failed.

Scenario B — Renewal with narrowed scope. The Commission grants renewal but restricts the scope, for example excluding certain EEI categories or requiring mandatory annual substitution progress reports from producers. This would create compliance complexity for smaller producers and accelerate consolidation in the European civil EEI sector. The defence read-across risk increases if consolidation reduces the number of facilities capable of manufacturing primary explosive compounds.

Scenario C — Extended delay or contested renewal. The Pack 28 assessment identifies substantive deficiencies in the substitution evidence base and requests additional data, extending the gap period by twelve to twenty-four months. Producers operate on national enforcement tolerance. This is the scenario that most concerns the defence industrial planning community, because it is the scenario most likely to prompt precautionary stockpiling of primary explosive raw materials — which would accelerate the lead compound supply tightness that REACH pressure is already beginning to create.

This analysis is AI-assisted and based entirely on open-source materials in the public domain. It does not constitute legal, regulatory, or procurement advice. Source evaluation follows NATO STANAG 2022 criteria. All classification: Open Source / Unclassified.